Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study

Autor: Braat, Arthur J A T *, Bruijnen, Rutger C G, van Rooij, Rob, Braat, Manon N G J A, Wessels, Frank J, van Leeuwaarde, Rachel S, van Treijen, Mark J C, de Herder, Wouter W, Hofland, Johannes, Tesselaar, Margot E T, de Jong, Hugo W A M, Lam, Marnix G E H
Zdroj: In The Lancet Oncology April 2020 21(4):561-570
Databáze: ScienceDirect